
Sign up to save your podcasts
Or
//The Wire//2100Z May 8, 2024//
//ROUTINE//
//BLUF: ASTRAZENECA PULLS COVID VACCINE FROM MARKET.//
-----BEGIN TEARLINE-----
-International Events-
Europe: The AstraZeneca COVID vaccine Covishield has been withdrawn from worldwide production. AstraZeneca claims that this drug was pulled from the market due to declining demand and a wide surplus of similar products from other brands.
-HomeFront-
USA: Pro-Palestine demonstrations continue at a variety of universities around the United States. Over the weekend, graduation ceremonies were disrupted at many universities as demonstrators begin to solidify what has so far been a less-than-coherent collection of positions/causes related to the pro-Palestine movement. AC: Lately, demonstrations in some cities have shifted to demanding universities divest from financial investment in (or any cooperation with) Israel as a condition for ceasing demonstrations. These efforts are unlikely to achieve the desired result, as 38 states have enacted anti-BDS laws specifically outlawing divestment from the state of Israel only. Consequently demonstrations, disruptions, and general unrest are likely to continue as the various controlling interests (from all participating factions) continue to entrench in varying ideological positions, and dig in for the long-haul this protest season.
-----END TEARLINE-----
Analyst Comments: AstraZeneca claims there is no link whatsoever to their drug being pulled from the market a few days after multiple international health groups (and AstraZeneca themselves) have admitted that a major side-effect of this vaccine is Thrombosis with Thrombocytopenia Syndrome (TTS), which results in “severe blood clotting events”. Before being pulled from the market, this vaccine was administered in over 150 nations.
Analyst: S2A1
//END REPORT//
4.9
241241 ratings
//The Wire//2100Z May 8, 2024//
//ROUTINE//
//BLUF: ASTRAZENECA PULLS COVID VACCINE FROM MARKET.//
-----BEGIN TEARLINE-----
-International Events-
Europe: The AstraZeneca COVID vaccine Covishield has been withdrawn from worldwide production. AstraZeneca claims that this drug was pulled from the market due to declining demand and a wide surplus of similar products from other brands.
-HomeFront-
USA: Pro-Palestine demonstrations continue at a variety of universities around the United States. Over the weekend, graduation ceremonies were disrupted at many universities as demonstrators begin to solidify what has so far been a less-than-coherent collection of positions/causes related to the pro-Palestine movement. AC: Lately, demonstrations in some cities have shifted to demanding universities divest from financial investment in (or any cooperation with) Israel as a condition for ceasing demonstrations. These efforts are unlikely to achieve the desired result, as 38 states have enacted anti-BDS laws specifically outlawing divestment from the state of Israel only. Consequently demonstrations, disruptions, and general unrest are likely to continue as the various controlling interests (from all participating factions) continue to entrench in varying ideological positions, and dig in for the long-haul this protest season.
-----END TEARLINE-----
Analyst Comments: AstraZeneca claims there is no link whatsoever to their drug being pulled from the market a few days after multiple international health groups (and AstraZeneca themselves) have admitted that a major side-effect of this vaccine is Thrombosis with Thrombocytopenia Syndrome (TTS), which results in “severe blood clotting events”. Before being pulled from the market, this vaccine was administered in over 150 nations.
Analyst: S2A1
//END REPORT//
450 Listeners
1,054 Listeners
3,721 Listeners
10,849 Listeners
6,374 Listeners
648 Listeners
40,994 Listeners
7,374 Listeners
1,173 Listeners
746 Listeners
510 Listeners
449 Listeners
618 Listeners
258 Listeners
93 Listeners